Publications

The Equity Impact Vaccines May Have On Averting Deaths And Medical Impoverishment In Developing Countries.

Chang, AY; Riumallo-Herl, C; Perales, NA; Clark, S; CLARK, A; Constenla, D; Garske, T; Jackson, ML; Jean, K; JIT, M; JONES, EO; Li, X; Suraratdecha, C; Bullock, O; Johnson, H; Brenzel, L; Verguet, S;

2018

Health affairs (Project Hope), (2018).37 2 10.1377/hlthaff.2017.0861.

Potential implementation strategies, acceptability, and feasibility of new and repurposed TB vaccines.

Pelzer, PT; SEELEY, J; Sun, FY; Tameris, M; Tao, L; Yanlin, Z; Moosan, H; WEERASURIYA, C; Asaria, M; Jayawardana, S; WHITE, RG; Harris, RC;

2018

PLOS Global Public Health, (2018).2 5 10.1371/journal.pgph.0000076.

Model Comparisons of the Effectiveness and Cost-Effectiveness of Vaccination: A Systematic Review of the Literature.

Drolet, M; Bénard, É; JIT, M; Hutubessy, R; Brisson, M;

2018

Value in health, (2018).21 10 10.1016/j.jval.2018.03.014.

Characterising antibody avidity in individuals of varied Mycobacterium tuberculosis infection status using surface plasmon resonance.

Kimuda, SG; Biraro, IA; Bagaya, BS; RAYNES, JG; COSE, S;

2018

PloS one, (2018).13 10 10.1371/journal.pone.0205102.

Evaluating dengue burden in Africa in passive fever surveillance and seroprevalence studies: protocol of field studies of the Dengue Vaccine Initiative.

Lim, JK; Carabali, M; Lee, J-S; Lee, K-S; Namkung, S; Lim, S-K; Ridde, V; Fernandes, J; Lell, B; Matendechero, SH; Esen, M; Andia, E; Oyembo, N; Barro, A; Bonnet, E; Njenga, SM; Agnandji, ST; Yaro, S; ALEXANDER, N; Yoon, I-K;

2018

BMJ open, (2018).8 1 10.1136/bmjopen-2017-017673.

Effect and cost-effectiveness of pneumococcal conjugate vaccination: a global modelling analysis.

Chen, C; Cervero Liceras, F; FLASCHE, S; Sidharta, S; Yoong, J; SUNDARAM, N; JIT, M;

2018

LANCET GLOBAL HEALTH, (2018).7 1 10.1016/S2214-109X(18)30422-4.

Human papillomavirus vaccine effectiveness by number of doses: Systematic review of data from national immunization programs.

Markowitz, LE; Drolet, M; Perez, N; JIT, M; Brisson, M;

2018

Vaccine, (2018).36 32 Pt 10.1016/j.vaccine.2018.01.057.

Tuberculosis susceptibility and protection in children.

BASU ROY, R; Whittaker, E; Seddon, JA; KAMPMANN, B;

2018

The Lancet. Infectious diseases, (2018).19 3 10.1016/S1473-3099(18)30157-9.

Tuberculosis vaccines: Opportunities and challenges.

Zhu, B; DOCKRELL, HM; Ottenhoff, TH M; Evans, TG; Zhang, Y;

2018

Respirology (Carlton, Vic), (2018).23 4 10.1111/resp.13245.

Functional antibodies against Plasmodium falciparum sporozoites are associated with a longer time to qPCR-detected infection among schoolchildren in Burkina Faso.

Barry, A; Behet, MC; Nébié, I; Lanke, K; GRIGNARD, L; Ouedraogo, A; Soulama, I; DRAKELEY, C; Sauerwein, R; Bolscher, JM; Dechering, KJ; Bousema, T; Tiono, AB; GONÇALVES, BP;

2018

Wellcome Open Research, (2018).3, 10.12688/wellcomeopenres.14932.1.